1. Home
  2. KRRO vs EMX Comparison

KRRO vs EMX Comparison

Compare KRRO & EMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRRO
  • EMX
  • Stock Information
  • Founded
  • KRRO 2014
  • EMX N/A
  • Country
  • KRRO United States
  • EMX Canada
  • Employees
  • KRRO N/A
  • EMX 40
  • Industry
  • KRRO Biotechnology: Pharmaceutical Preparations
  • EMX
  • Sector
  • KRRO Health Care
  • EMX
  • Exchange
  • KRRO Nasdaq
  • EMX Nasdaq
  • Market Cap
  • KRRO 209.6M
  • EMX 232.8M
  • IPO Year
  • KRRO 2019
  • EMX N/A
  • Fundamental
  • Price
  • KRRO $13.90
  • EMX $2.16
  • Analyst Decision
  • KRRO Strong Buy
  • EMX Strong Buy
  • Analyst Count
  • KRRO 7
  • EMX 1
  • Target Price
  • KRRO $106.33
  • EMX $5.00
  • AVG Volume (30 Days)
  • KRRO 110.5K
  • EMX 580.8K
  • Earning Date
  • KRRO 05-13-2025
  • EMX 05-12-2025
  • Dividend Yield
  • KRRO N/A
  • EMX N/A
  • EPS Growth
  • KRRO N/A
  • EMX N/A
  • EPS
  • KRRO N/A
  • EMX N/A
  • Revenue
  • KRRO $2,271,000.00
  • EMX $27,448,000.00
  • Revenue This Year
  • KRRO N/A
  • EMX N/A
  • Revenue Next Year
  • KRRO $20.00
  • EMX $9.92
  • P/E Ratio
  • KRRO N/A
  • EMX N/A
  • Revenue Growth
  • KRRO N/A
  • EMX 3.11
  • 52 Week Low
  • KRRO $11.13
  • EMX $1.59
  • 52 Week High
  • KRRO $98.00
  • EMX $2.18
  • Technical
  • Relative Strength Index (RSI)
  • KRRO 34.42
  • EMX 63.35
  • Support Level
  • KRRO $12.21
  • EMX $2.11
  • Resistance Level
  • KRRO $15.30
  • EMX $2.18
  • Average True Range (ATR)
  • KRRO 2.09
  • EMX 0.09
  • MACD
  • KRRO 0.21
  • EMX 0.02
  • Stochastic Oscillator
  • KRRO 38.74
  • EMX 90.48

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

About EMX EMX Royalty Corporation (Canada)

EMX Royalty Corp and its subsidiaries operate as a royalty and prospect generator engaged in exploring for and generating royalties from, metals and minerals properties. The company is a precious, and base metals royalty company. The Company augments royalty generation with royalty acquisitions and strategic investments. EMX's royalty and mineral property portfolio consists of properties in North America, Europe, Turkiye, Latin America, Morocco and Australia.

Share on Social Networks: